blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1434988

EP1434988 - TRANSGENIC KNOCKOUTS OF BACE-1 [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  12.03.2010
Database last updated on 12.06.2024
Most recent event   Tooltip12.03.2010Refusal of applicationpublished on 14.04.2010  [2010/15]
Applicant(s)For all designated states
ELAN PHARMACEUTICALS, INC.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company LLC
7000 Portage Road
Kalamazoo, MI 49001 / US
[N/P]
Former [2007/04]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company LLC
7000 Portage Road
Kalamazoo, MI 49001 / US
Former [2005/22]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
Pharmacia & Upjohn Company LLC
301 Henrietta Street
Kalamazoo, MI 49001 / US
Former [2004/28]For all designated states
Elan Pharmaceuticals, Inc.
800 Gateway Boulevard
South San Francisco, CA 94080 / US
For all designated states
PHARMACIA & UPJOHN COMPANY
301 Henrietta Street
Kalamazoo, Michigan 49001 / US
Inventor(s)01 / MCCONLOGUE, Lisa C.
150 Chapin Lane
Burlingame, CA 94010 / US
02 / GURNEY, Mark E.
Krokhals 5D
110 Reykjavik / IS
 [2004/28]
Representative(s)Hiebl, Inge Elisabeth
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2008/37]Hiebl, Inge Elisabeth
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Former [2005/02]Adam, Holger, Dr.
Kraus & Weisert, Patent- und Rechtsanwälte, Thomas-Wimmer-Ring 15
80539 München / DE
Former [2004/28]Hiebl, Inge Elisabeth
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date02719072.722.02.2002
[2004/28]
WO2002US05639
Priority number, dateUS2001027109223.02.2001         Original published format: US 271092
US2001027151426.02.2001         Original published format: US 271514
US2001029376225.05.2001         Original published format: US 293762
[2004/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02068955
Date:06.09.2002
Language:EN
[2002/36]
Type: A1 Application with search report 
No.:EP1434988
Date:07.07.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 06.09.2002 takes the place of the publication of the European patent application.
[2004/28]
Search report(s)International search report - published on:US06.09.2002
(Supplementary) European search report - dispatched on:EP02.11.2005
ClassificationIPC:G01N33/00, A01K67/00
[2004/28]
CPC:
C12N15/8509 (EP,US); A01K67/0276 (EP,US); A01K2217/072 (EP,US);
A01K2217/075 (EP,US); A01K2227/105 (EP,US); A01K2267/03 (EP,US);
A01K2267/0312 (EP,US); A01K2267/0393 (EP,US); C12N2800/30 (EP,US);
C12N2840/203 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2004/28]
Extension statesAL20.08.2003
LT20.08.2003
LV20.08.2003
MK20.08.2003
RO20.08.2003
SI20.08.2003
TitleGerman:TRANSGENE BACE-1-KNOCKOUTS[2004/28]
English:TRANSGENIC KNOCKOUTS OF BACE-1[2004/28]
French:ANIMAUX TRANSGENIQUES KNOCKOUT A GENE BACE-1 INACTIVE[2004/28]
Entry into regional phase20.08.2003National basic fee paid 
20.08.2003Search fee paid 
20.08.2003Designation fee(s) paid 
20.08.2003Examination fee paid 
Examination procedure20.09.2002Request for preliminary examination filed
International Preliminary Examining Authority: US
20.08.2003Examination requested  [2004/28]
24.09.2007Despatch of a communication from the examining division (Time limit: M06)
14.05.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
10.07.2008Reply to a communication from the examining division
11.11.2009Cancellation of oral proceeding that was planned for 09.12.2009
24.11.2009Despatch of communication that the application is refused, reason: substantive examination [2010/15]
04.12.2009Application refused, date of legal effect [2010/15]
09.12.2009Date of oral proceedings (cancelled)
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
10.07.2008Request for further processing filed
Fees paidRenewal fee
04.02.2004Renewal fee patent year 03
22.02.2005Renewal fee patent year 04
27.02.2006Renewal fee patent year 05
27.02.2007Renewal fee patent year 06
25.02.2008Renewal fee patent year 07
26.02.2009Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO0047618  (ELAN PHARM INC [US], et al) [X] 1-34 * page 56, line 19 - page 59, line 2; claims 108-111 *;
 [X]  - CAI H ET AL, "Physiological role of beta-site APP-cleaving enzyme (BACE): generation and characterization of BACE-deficient mice", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (2000), Database accession no. PREV200100087703, XP002350005 [X] 1-12,19-34 * abstract *
 [PX]  - LUO Y ET AL, "Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.", NATURE NEUROSCIENCE. MAR 2001, (200103), vol. 4, no. 3, ISSN 1097-6256, pages 231 - 232, XP002350002 [PX] 1-34 * the whole document *

DOI:   http://dx.doi.org/10.1038/85059
 [PX]  - CAI HUAIBIN ET AL, "BACE1 is the major beta-secretase for generation of Abeta peptides by neurons", NATURE NEUROSCIENCE, (200103), vol. 4, no. 3, ISSN 1097-6256, pages 233 - 234, XP002350003 [PX] 1-34 * the whole document *

DOI:   http://dx.doi.org/10.1038/85064
 [PX]  - ROBERDS S L ET AL, "BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: Implications for Alzheimer's disease therapeutics", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, GB, (2001), vol. 10, no. 12, ISSN 0964-6906, pages 1317 - 1324, XP002228077 [PX] 1-12,19-34 * the whole document *

DOI:   http://dx.doi.org/10.1093/hmg/10.12.1317
    [ ] - SOCIETY FOR NEUROSCIENCE ABSTRACTS, 30TH ANNUAL MEETING OF THE SOCIETY OF NEUROSCIENCE; NEW ORLEANS, LA, USA; NOVEMBER 04-09, 2000, (2000), vol. 26, no. 1-2, ISSN 0190-5295, pages Abstract No. - 276.4
International search[A]  - SINHA, S. ET AL., "Cellular mechanisms of beta-amyloid production and secretion", PROC. NATL. ACAD. SCI. USA, (199909), vol. 96, pages 11049 - 11053, XP002951621

DOI:   http://dx.doi.org/10.1073/pnas.96.20.11049
 [Y]  - VASSAR, R. ET AL., "beta-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane apartic protease BACE", SCIENCE, (19991022), vol. 286, pages 735 - 741, XP000914811

DOI:   http://dx.doi.org/10.1126/science.286.5440.735
 [Y]  - HUBER, G. ET AL., "cDNA cloning and molecular characterization of human brain metalloprotease MP 100: a beta-secretase candidate", JOURNAL OF NEUROCHEMISTRY, (1999), vol. 72, pages 1215 - 1223, XP000911070

DOI:   http://dx.doi.org/10.1046/j.1471-4159.1999.0721215.x
 [Y]  - SINHA, S. ET AL., "Purification and cloning of amyloid precursor protein beta-secretase from human brain", NATURE, (19991202), vol. 402, pages 537 - 540, XP000881765

DOI:   http://dx.doi.org/10.1038/990114
 [A]  - DE STROOPER, B. ET AL., "Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein", NATURE, (19980122), vol. 391, pages 387 - 390, XP001010557

DOI:   http://dx.doi.org/10.1038/34910
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.